Added to YB: 2026-04-15
Pitch date: 2026-04-14
ICCC [bullish]
ImmuCell Corporation
Author Info
Kreuzmann Investing is looking for the best opportunities in Small and Microcap companies around the world. Sign up for the newsletter.
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$74.7M
Pitch Price
N/A
Price Target
9.00
Dividend
N/A
EV/EBITDA
12.68
P/E
-120.40
EV/Sales
2.70
Sector
Biotechnology
Category
turnaround
Coiling the spring
ICCC (added to position): Q1 prelim rev +35% YoY US, +28% total despite limited impact from 2 new sales hires (3-9mo training). New mgmt paused $50M Re-Tain sink, boosted mfg yields/output, refocused on superior First Defense product. Trading 9.5x est 2026 EBIT of $7.16M w/ 24% rev growth to $34M possible. 13x EBIT = $9/share (30% upside) or 70% longer-term. Risks: growth sustainability unclear, capacity constraints at ~$34M, contamination.
Read full article (9 min)